True Link Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-975
Closed -$220K 116
2022
Q3
$220K Buy
+975
New +$236K 0.03% 124
2022
Q1
Sell
-250
Closed -$56K 136
2021
Q4
$56K Sell
250
-368
-60% -$77.7K 0.01% 450
2021
Q3
$131K Sell
618
-32
-5% -$7.37K 0.02% 304
2021
Q2
$158K Buy
650
+43
+7% +$10.6K 0.02% 244
2021
Q1
$151K Hold
607
0.02% 304
2020
Q4
$140K Buy
+607
New +$140K 0.02% 330

Other funds holding AMGN

True Link Financial Advisors's AMGN Position: Q4 2022 in Review

True Link Financial Advisors sold out of Amgen (AMGN) in Q4 2022, closing a stake of 975 shares — an estimated $220K sold.

True Link Financial Advisors first reported a position in AMGN in Q4 2020 and held it in 6 quarters. The position peaked at $220K in Q3 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • True Link Financial Advisors reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • True Link Financial Advisors sold 975 Amgen shares in Q4 2022, an estimated $220K.
  • True Link Financial Advisors first reported a position in Amgen in Q4 2020 and held it in 6 quarters.
  • True Link Financial Advisors's Amgen position peaked at $220K in Q3 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on True Link Financial Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.